Abstract
Our purpose in organizing this seminar was threefold:
-
1.
to evaluate the instrument of cost-benefit analysis from a broader perspective, namely not only from a methodological or technical point of view but also embedded in an environmental and social context;
-
2.
to apply that methodology to the case of a new drug (Nitroderm TTS) which had been studied extensively and to the various social and economic conditions in six different countries, and to present data; and
-
3.
to encourage an interdisciplinary dialogue between policy-makers, economists, sociologists, physicians, and drug manufacturers, in critically reviewing the data presented at the symposium.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Joglekar P, Paterson ML (1986) A typology of cost-benefit analyses in the health care sector. In: Horisberger B, van Eimeren W (eds) Die Kosten-Nutzen-Analyse. Methodik und Anwendung am Beispiel von Medikamenten. Springer, Berlin Heidelberg New York
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dinkel, R., Horisberger, B. (1988). Envoi. In: van Eimeren, W., Horisberger, B. (eds) Socioeconomic Evaluation of Drug Therapy. Health Systems Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61366-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-61366-1_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64811-3
Online ISBN: 978-3-642-61366-1
eBook Packages: Springer Book Archive